TELA Bio (TELA) Raw Materials (2023 - 2025)
TELA Bio (TELA) posted quarterly Raw Materials of $118000.0 for Q4 2025, down 13.24% year-over-year from $136000.0 in Q4 2024, and down 13.24% quarter-over-quarter from $136000.0 in Q4 2024.
TELA Bio (TELA) Raw Materials (2023 - 2025) Analysis & Trends
TELA Bio's Raw Materials history runs 3 years deep, the most recent figure standing at $118000.0 for Q4 2025.
- In Q4 2025, Raw Materials fell 13.24% year-over-year to $118000.0; the TTM figure through Dec 2025 stood at $118000.0 (down 13.24% YoY), while the FY2025 annual figure was $118000.0, down 13.24% from the prior year.
- Raw Materials for Q4 2025 stood at $118000.0, down from $136000.0 in the prior quarter.
- The five-year high for Raw Materials was $136000.0 in Q4 2024, with the low at $60000.0 in Q4 2023.
- The 3-year median for Raw Materials is $118000.0 (2025), against an average of $104666.7.
- The sharpest annual moves came in 2024 and 2025: Raw Materials jumped 126.67% in 2024, then declined 13.24% in 2025.
- TELA Bio's Raw Materials stood at $60000.0 in 2023, then surged by 126.67% to $136000.0 in 2024, then declined by 13.24% to $118000.0 in 2025.
- Business Quant data shows TELA's Raw Materials at $118000.0 in Q4 2025, $136000.0 in Q4 2024, and $60000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | TELA Bio | 37.05 Mn | 6.63 Mn | 13.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 136,000.00 |
| Dec 31, 2023 | 60,000.00 |